Semaglutide → Abdominal pain upper — Audit-grade candidate (scan)

← All findings ⬇ Download signed audit packet

Ledger entry · candidate

Semaglutide → Abdominal pain upper — Audit-grade candidate (scan)

Drug: semaglutide · AE: Abdominal pain upper

Discovered via single-drug scan of semaglutide. PRR = 3.71 (95% CI 3.49–3.95), n = 956 cases. Pre-reg locked at submission time.

Disproportionality

PRR: 3.7111284816225214 (95% CI 3.49–3.95)
Yates χ²: 1900.5355564897447
Cases (case-drug + AE): n = 956
Verdict: PASSES_ALL_GATES — PRR=3.71 (95% CI 3.49–3.95), n=956 cases; flagged for clinical expert review, NOT for external escalation without manual verification

Top reactions in cohort

MedDRA PT	n
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: 22fefb73bbf42920cbb84fda9791ea3d18686a49